{[['
']]}
']]}
BOOK DETAILS
| The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes – “Mechanisms and Models of Drug Interactions” and “Antimicrobial Drug Interactions”. This volume, “Antimicrobial Drug Interactions,” delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included. Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners. | |||
Table of contents : Front Matter ....Pages i-xvi Beta-Lactam Antibiotics (Larry H. Danziger, Karolyn S. Horn)....Pages 1-56 Macrolides, Azalides, and Ketolides (Manjunath P. Pai)....Pages 57-86 Quinolones (David R. P. Guay)....Pages 87-138 Glycopeptides, Lipopeptides, and Lipoglycopeptides (Mary A. Ullman, John C. Rotschafer)....Pages 139-166 Miscellaneous Antibiotics (Gregory M. Susla)....Pages 167-219 Drugs for Tuberculosis (Rocsanna Namdar, Charles A. Peloquin)....Pages 221-253 Drug Interactions in HIV: Protease and Integrase Inhibitors (Parul Patel, Stan Louie)....Pages 255-295 Drug Interactions in HIV: Nucleoside, Nucleotide, and Nonnucleoside Reverse Transcriptase Inhibitors and Entry Inhibitors (Lauren R. Cirrincione, Kimberly K. Scarsi)....Pages 297-356 Hepatitis B and Hepatitis C Antiviral Agents (Christine E. MacBrayne, Jennifer J. Kiser)....Pages 357-380 Drug Interactions of Non-HIV Antiviral Agents (Douglas N. Fish)....Pages 381-424 Antifungal Agents (Jarrett R. Amsden, Paul O. Gubbins)....Pages 425-501 Drug-Drug Interactions of Antimalarial Drugs (Waheed A. Adedeji, Tunde Balogun, Fatai A. Fehintola, Gene D. Morse)....Pages 503-514 Antiprotozoal and Anthelmintic Agents (Tony K. L. Kiang, Kyle John Wilby, Mary H. H. Ensom)....Pages 515-549 Back Matter ....Pages 551-565 |
Chapisha Maoni